Literature DB >> 20224052

Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.

Marc Revermann1, Manuel Schloss, Eduardo Barbosa-Sicard, Anja Mieth, Stefan Liebner, Christophe Morisseau, Gerd Geisslinger, Ralph T Schermuly, Ingrid Fleming, Bruce D Hammock, Ralf P Brandes.   

Abstract

OBJECTIVE: Epoxyeicosatrienoic acids (EETs) have antiinflammatory effects and are required for normal endothelial function. The soluble epoxide hydrolase (sEH) metabolizes EETs to their less active diols. We hypothesized that knockout and inhibition of sEH prevents neointima formation in hyperlipidemic ApoE(-/-) mice. METHODS AND
RESULTS: Inhibition of sEH by 12-(3-adamantan-1-yl-ureido) dodecanoic acid or knockout of the enzyme significantly increased plasma EET levels. sEH activity was detectable in femoral and carotid arteries. sEH knockout or inhibition resulted in a significant reduction of neointima formation in the femoral artery cuff model but not following carotid artery ligation. Although macrophage infiltration occurred abundantly at the site of cuff placement in both sEH(+/+) and sEH(-/-), the expression of proinflammatory genes was significantly reduced in femoral arteries from sEH(-/-) mice. Moreover, an in vivo 5-bromo-2'-deoxyuridine assay revealed that smooth muscle cell proliferation at the site of cuff placement was attenuated in sEH knockout and sEH inhibitor-treated animals.
CONCLUSION: These observations suggest that inhibition of sEH prevents vascular remodeling in an inflammatory model but not in a blood flow-dependent model of neointima formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224052      PMCID: PMC2919323          DOI: 10.1161/ATVBAHA.110.204099

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  34 in total

Review 1.  A blast from the past: clearance of apoptotic cells regulates immune responses.

Authors:  John Savill; Ian Dransfield; Chris Gregory; Chris Haslett
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

2.  Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury.

Authors:  J Fingerle; Y P Au; A W Clowes; M A Reidy
Journal:  Arteriosclerosis       Date:  1990 Nov-Dec

3.  Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development.

Authors:  T Kawasaki; M Dewerchin; H R Lijnen; I Vreys; J Vermylen; M F Hoylaerts
Journal:  Circ Res       Date:  2001-02-02       Impact factor: 17.367

4.  Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.

Authors:  Benjamin B Davis; David A Thompson; Laura L Howard; Christophe Morisseau; Bruce D Hammock; Robert H Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

5.  Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.

Authors:  John D Imig; Xueying Zhao; Jorge H Capdevila; Christophe Morisseau; Bruce D Hammock
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

6.  Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.

Authors:  Christophe Morisseau; Marvin H Goodrow; John W Newman; Craig E Wheelock; Deanna L Dowdy; Bruce D Hammock
Journal:  Biochem Pharmacol       Date:  2002-05-01       Impact factor: 5.858

7.  Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.

Authors:  John M Seubert; Christopher J Sinal; Joan Graves; Laura M DeGraff; J Alyce Bradbury; Craig R Lee; Kerry Goralski; Michelle A Carey; Ayala Luria; John W Newman; Bruce D Hammock; John R Falck; Holly Roberts; Howard A Rockman; Elizabeth Murphy; Darryl C Zeldin
Journal:  Circ Res       Date:  2006-07-20       Impact factor: 17.367

8.  Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice.

Authors:  J H Lardenoye; D J Delsing; M R de Vries; M M Deckers; H M Princen; L M Havekes; V W van Hinsbergh; J H van Bockel; P H Quax
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

9.  Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.

Authors:  Jianxin Sun; XinXin Sui; J Alyce Bradbury; Darryl C Zeldin; Michael S Conte; James K Liao
Journal:  Circ Res       Date:  2002-05-17       Impact factor: 17.367

10.  Toll-like receptor 4 is involved in outward arterial remodeling.

Authors:  Saskia C G Hollestelle; Margreet R De Vries; J Karlijn Van Keulen; Arjan H Schoneveld; Aryan Vink; Chaylendra F Strijder; Ben J Van Middelaar; Gerard Pasterkamp; Paul H A Quax; Dominique P V De Kleijn
Journal:  Circulation       Date:  2003-12-29       Impact factor: 29.690

View more
  26 in total

1.  Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols.

Authors:  Timo Frömel; Benno Jungblut; Jiong Hu; Caroline Trouvain; Eduardo Barbosa-Sicard; Rüdiger Popp; Stefan Liebner; Stefanie Dimmeler; Bruce D Hammock; Ingrid Fleming
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

Review 2.  Lipid mediators in immune regulation and resolution.

Authors:  Derek W Gilroy; David Bishop-Bailey
Journal:  Br J Pharmacol       Date:  2019-03-01       Impact factor: 8.739

3.  A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm.

Authors:  M Revermann; A Mieth; L Popescu; A Paulke; M Wurglics; M Pellowska; A S Fischer; R Steri; T J Maier; R T Schermuly; G Geisslinger; M Schubert-Zsilavecz; R P Brandes; D Steinhilber
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

4.  Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.

Authors:  Silvia Diani-Moore; Yuliang Ma; Steven S Gross; Arleen B Rifkind
Journal:  Drug Metab Dispos       Date:  2013-12-05       Impact factor: 3.922

5.  Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease.

Authors:  Oliver Jung; Felix Jansen; Anja Mieth; Eduardo Barbosa-Sicard; Rainer U Pliquett; Andrea Babelova; Christophe Morisseau; Sung H Hwang; Cindy Tsai; Bruce D Hammock; Liliana Schaefer; Gerd Geisslinger; Kerstin Amann; Ralf P Brandes
Journal:  PLoS One       Date:  2010-08-04       Impact factor: 3.240

6.  Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.

Authors:  Dan Li; Yajin Liu; Xu Zhang; Huizhen Lv; Wei Pang; Xiaoli Sun; Li-Ming Gan; Bruce D Hammock; Ding Ai; Yi Zhu
Journal:  J Mol Cell Cardiol       Date:  2016-08-03       Impact factor: 5.000

Review 7.  Roles of the epoxygenase CYP2J2 in the endothelium.

Authors:  Ara Askari; Scott J Thomson; Matthew L Edin; Darryl C Zeldin; David Bishop-Bailey
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-03-06       Impact factor: 3.072

8.  Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury.

Authors:  Kenneth I Strauss; Artiom Gruzdev; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-08-16       Impact factor: 3.072

Review 9.  Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer.

Authors:  Guodong Zhang; Sean Kodani; Bruce D Hammock
Journal:  Prog Lipid Res       Date:  2013-12-15       Impact factor: 16.195

10.  Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase.

Authors:  Xiaoyong Tong; Alok R Khandelwal; Xiaojuan Wu; Zaicheng Xu; Weimin Yu; Caiyu Chen; Wanzhou Zhao; Jian Yang; Zhexue Qin; Robert M Weisbrod; Francesca Seta; Tetsuro Ago; Kin Sing Stephen Lee; Bruce D Hammock; Junichi Sadoshima; Richard A Cohen; Chunyu Zeng
Journal:  J Mol Cell Cardiol       Date:  2016-01-23       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.